Preserving and rebuilding lean muscle is one of the most important predictors of long-term metabolic health
However, the drug is associated with mild to moderate gastrointestinal side effects, as well as potential brain-related side effects such as irritability, anxiety, and sleep troubles
Food and Drug Administration (FDA) granted accelerated approval of semaglutide (Wegovy), a peptide-based long-acting GLP-1 receptor (GLP1R) agonist, for patients with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced liver fibrosis
Its important to remember that everyone responds differently to medications: some people may experience a lot of side effects, while others could experience none at all
Food cannot reproduce the rapid, high-level GLP-1 receptor activation that prescription GLP-1 medications produce
Reviewed by the PeptideMind Team Updated July 15, 2026 GLP-3 (Retatrutide) Dosage Guide, Benefits & Side Effects This triple GIP/GLP-1/glucagon agonist produced up to 24-29% body weight loss in trials, alongside liver fat, kidney, and cardiovascular improvements
